A detailed history of Two Sigma Securities, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Two Sigma Securities, LLC holds 1,375 shares of NTRA stock, worth $280,885. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,375
Previous 10,609 87.04%
Holding current value
$280,885
Previous $1.79 Million 87.67%
% of portfolio
0.04%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$133.66 - $181.11 $1.23 Million - $1.67 Million
-9,234 Reduced 87.04%
1,375 $221,000
Q2 2025

Aug 14, 2025

BUY
$132.23 - $171.87 $1.4 Million - $1.82 Million
10,609 New
10,609 $1.79 Million
Q4 2024

Feb 14, 2025

BUY
$117.67 - $174.0 $199,803 - $295,452
1,698 New
1,698 $268,000
Q2 2024

Aug 14, 2024

BUY
$85.28 - $112.6 $216,611 - $286,004
2,540 New
2,540 $275,000
Q4 2023

Feb 14, 2024

BUY
$37.55 - $62.64 $251,584 - $419,688
6,700 New
6,700 $419,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $19.8B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.